# ExosoMe as Integrative Tool for pRognostic Stratification of Adverse Cardiac remodeLing in stEmi Patients: the MIRACLE Study

> **NCT06070974** · — · UNKNOWN · sponsor: **Centro Cardiologico Monzino** · enrollment: 100 (estimated)

## Conditions studied

- STEMI

## Interventions

- **DIAGNOSTIC_TEST:** CMR and blood collection

## Key facts

- **NCT ID:** NCT06070974
- **Lead sponsor:** Centro Cardiologico Monzino
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-03
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06070974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06070974, "ExosoMe as Integrative Tool for pRognostic Stratification of Adverse Cardiac remodeLing in stEmi Patients: the MIRACLE Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06070974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*